FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966620439> ?p ?o ?g. }

• W1966620439 endingPage "1009" @default.
• W1966620439 startingPage "1004" @default.
• W1966620439 abstract "Because tumorigenesis frequently involves the dysfunction of cell cycle-related proteins, we examined the effect of mutations in CDK inhibitor p16 and its linked genomic loci p15, cl.B, and 1063.7 on the growth of primary adult T-cell leukemia (ATL) cells. Southern blot analysis of primary ATL cells showed a significantly higher incidence of p16 gene alteration in acute ATL than in chronic ATL [67.7% (23/34) vs. 26.1% (6/23), respectively; p<0.003]. Similarly, polymerase chain reaction (PCR) analysis of p16 exon 2 revealed a higher incidence of alteration in acute ATL than in chronic ATL [52.9% (18/34) vs. 26.1% (6/23), respectively; p<0.05]. PCR-single strand conformation polymorphism analysis of exons 1 and 2 of p16 showed no mutations in the patients, with normal pattern by Southern blotting or PCR analysis. Notably five of six chronic ATL patients with abnormal p16 genes progressed to acute crisis within 4 months. PCR analysis of the p16 linked loci 1063.7, p15 exon 2, and cl.B found homozygous deletion in 55.9%, 20.6%, and 2.9% of acute ATL cells and 39.1%, 13.0%, and 0% of chronic ATL cells, respectively, showing no relationship of homozygous deletion in either loci with disease subtypes. In most cases, deletions were seen in multiple genes, including p16. Acute ATL cells had a higher frequency of multigene deletions than chronic ATL cells [44.1% vs. 17.4%; p<0.05]. When leukemic cells were analyzed for interleukin 2 (IL-2) responsive growth, only p16 gene alteration was directly associated with leukemic cell growth activity. Among leukemic cells showing high IL-2 responsiveness, 73.1% (19/26) had p16 gene alteration vs. 27.8% (5/18) of leukemic cells that showed low IL-2 responsiveness (p<0.005). p16 gene alteration was found in 73.3% (14/19) of leukemic cells showing high autonomous growth rates but in only 40.0% (10/25) of those leukemic cells showing low autonomous growth (p<0.03). These results suggest the following: alteration of p16-related genomic regions in ATL is usually a wide rearrangement including the p16 gene; within this region, only p16 gene alteration is associated with disease aggressiveness; and p16 gene deletion may be a proximate event in leukemogenesis." @default.
• W1966620439 created "2016-06-24" @default.
• W1966620439 creator A5012931208 @default.
• W1966620439 creator A5052687126 @default.
• W1966620439 creator A5052778790 @default.
• W1966620439 creator A5083986881 @default.
• W1966620439 creator A5086005516 @default.
• W1966620439 creator A5089860470 @default.
• W1966620439 creator A5091599114 @default.
• W1966620439 creator A5091914884 @default.
• W1966620439 date "1999-06-01" @default.
• W1966620439 modified "2023-10-10" @default.
• W1966620439 title "Alteration of p16 (CDKN2) gene is associated with interleukin-2–induced tumor cell growth in adult T-cell leukemia" @default.
• W1966620439 cites W108417128 @default.
• W1966620439 cites W1506183674 @default.
• W1966620439 cites W1542367364 @default.
• W1966620439 cites W1552964273 @default.
• W1966620439 cites W1560943589 @default.
• W1966620439 cites W169454248 @default.
• W1966620439 cites W1937420266 @default.
• W1966620439 cites W1981906666 @default.
• W1966620439 cites W1982890924 @default.
• W1966620439 cites W1983348452 @default.
• W1966620439 cites W1996027687 @default.
• W1966620439 cites W1997073961 @default.
• W1966620439 cites W1998624429 @default.
• W1966620439 cites W200461798 @default.
• W1966620439 cites W2009621572 @default.
• W1966620439 cites W2010493387 @default.
• W1966620439 cites W2015066175 @default.
• W1966620439 cites W2015519364 @default.
• W1966620439 cites W2016534065 @default.
• W1966620439 cites W2034613001 @default.
• W1966620439 cites W2035882662 @default.
• W1966620439 cites W2048022927 @default.
• W1966620439 cites W2063450941 @default.
• W1966620439 cites W2066848701 @default.
• W1966620439 cites W2088706525 @default.
• W1966620439 cites W2089218510 @default.
• W1966620439 cites W2095383081 @default.
• W1966620439 cites W2125995804 @default.
• W1966620439 cites W2144192014 @default.
• W1966620439 cites W2272086863 @default.
• W1966620439 cites W2298281322 @default.
• W1966620439 cites W2301048882 @default.
• W1966620439 cites W2409731915 @default.
• W1966620439 cites W2415720595 @default.
• W1966620439 cites W2417729178 @default.
• W1966620439 cites W4248878862 @default.
• W1966620439 doi "https://doi.org/10.1016/s0301-472x(99)00035-1" @default.
• W1966620439 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10378889" @default.
• W1966620439 hasPublicationYear "1999" @default.
• W1966620439 type Work @default.
• W1966620439 sameAs 1966620439 @default.
• W1966620439 citedByCount "12" @default.
• W1966620439 countsByYear W19666204392021 @default.
• W1966620439 countsByYear W19666204392023 @default.
• W1966620439 crossrefType "journal-article" @default.
• W1966620439 hasAuthorship W1966620439A5012931208 @default.
• W1966620439 hasAuthorship W1966620439A5052687126 @default.
• W1966620439 hasAuthorship W1966620439A5052778790 @default.
• W1966620439 hasAuthorship W1966620439A5083986881 @default.
• W1966620439 hasAuthorship W1966620439A5086005516 @default.
• W1966620439 hasAuthorship W1966620439A5089860470 @default.
• W1966620439 hasAuthorship W1966620439A5091599114 @default.
• W1966620439 hasAuthorship W1966620439A5091914884 @default.
• W1966620439 hasBestOaLocation W19666204391 @default.
• W1966620439 hasConcept C104317684 @default.
• W1966620439 hasConcept C133307689 @default.
• W1966620439 hasConcept C153911025 @default.
• W1966620439 hasConcept C203014093 @default.
• W1966620439 hasConcept C2776913467 @default.
• W1966620439 hasConcept C2778461978 @default.
• W1966620439 hasConcept C29537977 @default.
• W1966620439 hasConcept C36823959 @default.
• W1966620439 hasConcept C49105822 @default.
• W1966620439 hasConcept C502942594 @default.
• W1966620439 hasConcept C54355233 @default.
• W1966620439 hasConcept C555283112 @default.
• W1966620439 hasConcept C85265743 @default.
• W1966620439 hasConcept C86803240 @default.
• W1966620439 hasConceptScore W1966620439C104317684 @default.
• W1966620439 hasConceptScore W1966620439C133307689 @default.
• W1966620439 hasConceptScore W1966620439C153911025 @default.
• W1966620439 hasConceptScore W1966620439C203014093 @default.
• W1966620439 hasConceptScore W1966620439C2776913467 @default.
• W1966620439 hasConceptScore W1966620439C2778461978 @default.
• W1966620439 hasConceptScore W1966620439C29537977 @default.
• W1966620439 hasConceptScore W1966620439C36823959 @default.
• W1966620439 hasConceptScore W1966620439C49105822 @default.
• W1966620439 hasConceptScore W1966620439C502942594 @default.
• W1966620439 hasConceptScore W1966620439C54355233 @default.
• W1966620439 hasConceptScore W1966620439C555283112 @default.
• W1966620439 hasConceptScore W1966620439C85265743 @default.
• W1966620439 hasConceptScore W1966620439C86803240 @default.
• W1966620439 hasFunder F4320320912 @default.
• W1966620439 hasIssue "6" @default.
• W1966620439 hasLocation W19666204391 @default.

• next